sulfinpyrazone has been researched along with Vertigo in 1 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Vertigo: An illusion of movement, either of the external world revolving around the individual or of the individual revolving in space. Vertigo may be associated with disorders of the inner ear (EAR, INNER); VESTIBULAR NERVE; BRAINSTEM; or CEREBRAL CORTEX. Lesions in the TEMPORAL LOBE and PARIETAL LOBE may be associated with FOCAL SEIZURES that may feature vertigo as an ictal manifestation. (From Adams et al., Principles of Neurology, 6th ed, pp300-1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bogousslavsky, J | 1 |
| Regli, F | 1 |
| Rousselle, J | 1 |
| Schmidt, PM | 1 |
1 other study available for sulfinpyrazone and Vertigo
| Article | Year |
|---|---|
[Cerebrovascular complications of thrombocytosis].
Topics: Aged; Aspirin; Blindness; Cerebellar Diseases; Cerebellopontine Angle; Facial Paralysis; Female; Hum | 1983 |